The announcement of a $500 million convertible senior notes offering by Core Scientific could affect its stock price as it impacts the company's financial structure. The offering is significant in size and targets institutional buyers, indicating a strategic financial move. However, the impact on stock price is uncertain as it depends on market conditions and investor reception.